Ann: Quarter 4 Update, page-3

This is an outstanding 4C and clearly demonstrates LSH's emergence from a penny stock to a growth story.

In fact, the numbers in here offer a glimpse of what is about to unfold in the not too distant future.

Revenues of 73k vs. Product manufacturing & operating costs of $31 = juicy margins.

Had to do a double take.

At $195 a vape that's around a measely 173 vapes sold.

Get that number up to a very achievable 10,000 vapes and the share price will be well north of here.

Make no mistake medical cannabis vaping with oils is a huge new market with political, medical & moral questions that had stopped the industry in its tracks - until now.

LSH's medihale solution answers all these questions. From the article in Small Caps this morning:

Medihale devices

"According to Lifespot, cannabis offers a medical solution for many patients.

The company claims Medihale contains none of the additives that are known to cause lung damage.

Lifespot chief executive officer Matthew Golden previous told Small Caps Medihale was similar to an insulin pen. It contains a cartridge that cannot be tampered with or refilled.

The device also offers users dose precision.

Both of these inclusions prevent black market use of the device and deliberate or unintentional dose increases."

Let's not forget the fingerprint youthproof lockout either.

This company is cashed up ~ around $4million by my calcs - with a big name North American backer and news of the trial to drop this quarter.

Only a matter of time before we see 30 cents.

Imo